GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Long Term Debt 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- GoodRx Holdings, Inc. Class A Common Stock long term debt as of December 31, 2025: 533.1M, a 0.06% increase year-over-year.
- GoodRx Holdings, Inc. Class A Common Stock long term debt for 2025 were 533.1M, a 0.06% increase from 2024.
- GoodRx Holdings, Inc. Class A Common Stock long term debt for 2024 were 532.8M, a 23.47% decrease from 2023.
- GoodRx Holdings, Inc. Class A Common Stock long term debt for 2023 were 696.1M, a 1.39% decrease from 2022.
- GoodRx Holdings, Inc. Class A Common Stock long term debt for 2022 were 705.9M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| GoodRx Holdings, Inc. Class A Common Stock Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $533 |
| 2024 | $533 |
| 2023 | $696 |
| 2022 | $706 |
| 2021 | $689 |
| 2020 | $693 |
GoodRx Holdings, Inc. Class A Common Stock Long Term Debt — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GDRX's long term debt history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's long term debt by year and by quarter, including the growth rate.